Frontlight ResearchEarly access
CompletedNo phase
Validation of the MBI-C Scale in French
Key facts
- Who runs it
- University Hospital, Toulouse
- Where
- France5 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 170 people enrolled
- Started
- 26 Jun 2023
- Ended
- 17 Oct 2024
- Type of study
- Observational
- Treatments tested
- MBI-C Scale in French
- Record updated
- 10 April 2025
Who can take part
- Age
- 50 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Patient presenting a subjective cognitive complaint (SCP) or mild cognitive impairment (MCI) for at least 6 months
- Patient with a relative visiting them at least once a week
- No opposition from the patient and his loved one
Who cannot take part
- Neuropsychiatric symptoms secondary to concomitant treatments, or to a medical or psychiatric pathology
- Concomitant major depressive episode (DSM-V)
- Presence of concomitant pathologies preventing participation in the study (taking tests)
- Patient presenting criteria for major neurocognitive disorder according to DSM-V criteria
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to validate the French version of the Mild Behavioral Impairment-Checklist (MBI-C) scale, hypothetically effective for measuring behavioral symptoms in patients presenting with a subjective cognitive complaint or mild cognitive impairment (MCI).
The group in the trial
- MBI-C Scale in French
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 10 April 2025